Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

956 evidence items · page 14 / 39

3.15 RRIn children treated with sulphadoxine-pyrimethamine (SP), the prevalence of anaemia at day 14 was significantly lower than in those treated with chloroquine (CQ), with a relative risk of 3.15 (95% CI: 1.33–7.42, P = 0.008).

Burkina Fasoanémiepublished 2002Tropical medicine & international health : TM & IHeurope_pmcdocument of 6 observationsDOI 10.1046/j.1365-3156.2002.00952.x

41.9 %In Burkina Faso, malaria prevalence among pregnant women at first antenatal care visit was 41.9% (592 of 1413).

Burkina Fasopaludismeobserved between May, 2010, and August, 2014PubMeddocument of 8 observations

Across species, biting was predominantly nocturnal, with most activity between 22:00 and 05:00.

Burkina FasopaludismeHAL · Unilimdocument of 87 observations

46 samplesA total of 46 RSV-positive samples were identified among febrile children with acute respiratory tract infection across Ghana, Gabon, Tanzania, and Burkina Faso between 2014 and 2017.

Burkina Faso · Gabon · Ghana · Tanzanierespiratory syncytial virus (RSV)observed 2014 and 2017published 2021Tropical medicine & international health : TM & IHeurope_pmcdocument of 5 observations

10.7 %In children who received RTS,S/AS01E vaccine in Burkina Faso and Mali, 10.7% showed a 10-fold increase in anti-CSP IgG antibody titres post-2019 as measured by GSK ELISA.

Burkina Faso · Malipaludismeobserved post-2019HAL · Unilimdocument of 105 observations

30 %In the town of Koudougou, 30% of households living less than 500 metres from waste have a high risk of malaria contamination.

Burkina FasopaludismeHAL · Unilimdocument of 110 observations

9 foldPatients with polymicrobial blood infections showed a 9-fold higher risk factor for not surviving their febrile illness.

Burkina Fasofebrile illness · polymicrobial blood infectionspublished 2016PLoS neglected tropical diseaseseurope_pmcdocument of 4 observations

46 %A phase 3 clinical trial of RTS,S/AS01 across eleven sub-Saharan African sites demonstrated a vaccine efficacy against clinical malaria of ~46% in children aged 5–17 months.

Burkina FasopaludismeHAL · Unilimdocument of 39 observations

50 %Parmi les 16 cas positifs pour le virus de l'hépatite A, huit (50 %) étaient âgés de moins de 15 ans.

Burkina Fasovirus de l'hépatite AHAL · Unilimdocument of 26 observations

123 infective_bites_per_person_per_yearIn Gaoua, the entomological inoculation rate (EIR) was 123 infective bites per person per year in year 1.

Burkina Fasopaludismeobserved year 1HAL · Unilimdocument of 87 observations

77 %Sporozoite rates were significantly reduced by >77% for two weeks following the mass drug administrations of ivermectin in treatment villages.

Burkina Fasopaludismepublished 2014Malaria journaleurope_pmcdocument of 3 observations

6.9 %Administering 3 or more doses of intermittent preventive therapy in pregnancy (IPTp) to all women would decrease the incidence of low birth weight from 9.9% to 6.9%.

Burkina Fasofaible poids de naissancepublished 2018American journal of public healtheurope_pmcdocument of 3 observationsDOI 10.2105/ajph.2017.304251

69 %Only 69% of travellers correctly took malaria chemoprophylaxis.

Burkina FasopaludismeHAL · Unilimdocument of 83 observations

89 %In Burkina Faso, a quasi-experimental study revealed that SMC administration under programmatic conditions reduced malaria incidence by 89% four weeks after administration and by 62% five to six weeks later, among both children under 5 and older children.

Burkina FasopaludismeHAL · Unilimdocument of 147 observations

3.93 %In Sector 8, the morbidity rate for severe malaria among children under 5 years of age was 3.93% in 2022.

Burkina Fasopaludismeobserved 2022HAL · Unilimdocument of 110 observations

40 %In children with inconclusive results (PfHRP2+/pLDH- only), previous antimalarial treatment was reported in 16 children with malaria negative microscopy (16/40; 40%).

Burkina Fasopaludismepublished 2019PloS oneeurope_pmcdocument of 12 observations

81.8 %For secundigravidae, a prediction model using IL-10 and sTNF-RII had a sensitivity of 81.8% and specificity of 100.0% for diagnosing malaria during pregnancy.

Burkina Fasopaludismepublished 2017Biomarker researcheurope_pmcdocument of 5 observations

0.77 p-valueNo significant differences in perinatal mortality were found between treatment arms (p = 0.77).

Burkina Fasoperinatal mortalitypublished 2019Malaria journaleurope_pmcdocument of 6 observations

18.6 %In Nanoro, Burkina Faso, the Pfdhfr/Pfdhps quintuple mutant IRN-436A437G rose from 18.6% in 2010–2012 to 58.3% in 2020.

Burkina Fasopaludismeobserved 2010-2012published 2024Scientific reportsPubMeddocument of 4 observations

33.7 %The frequency of the pfcrt76T mutant allele was 33.7% in the study area.

Burkina Fasopaludismeobserved 2012 and 2013HAL · Unilimdocument of 2 observations

290 mmPatients with ovarian hyperstimulation syndrome required decompressive paracentesis at the median Ascites Index above 290 mm.

Burkina Fasoovarian hyperstimulation syndromepublished 2018Journal of ultrasonographyeurope_pmcdocument of 5 observations

67 casesOf the 306 patients, 67 had Plasmodium falciparum malaria, including two mixed infections with Plasmodium malariae.

Burkina FasopaludismeHAL · Unilimdocument of 83 observations

The sporozoite infection rate for An. arabiensis was higher than An. gambiae s.s. at both Dioulassoba and Kodeni.

Burkina Fasopaludismeobserved 2008published 2012Parasites & vectorseurope_pmcdocument of 5 observationsDOI 10.1186/1756-3305-5-127

54 %Malaria prevalence was 54.0% in primigravidae.

Burkina Fasopaludismepublished 2020Clinical nutrition (Edinburgh, Scotland)europe_pmcdocument of 7 observationsDOI 10.1016/j.clnu.2019.01.016

12 patientsBlood culture diagnosed bacterial bloodstream infection in 12 patients among 75 children with severe febrile illness in Burkina Faso.

Burkina Fasobacterial bloodstream infectionpublished 2016PLoS neglected tropical diseaseseurope_pmcdocument of 4 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.